Question:

Write on the various anticoagulation options in extracorporeal circuits.

Show Hint

Careful monitoring of anticoagulation levels in extracorporeal circuits is essential to balance the risk of clot formation and bleeding.
Updated On: Dec 11, 2025
Hide Solution
collegedunia
Verified By Collegedunia

Solution and Explanation

Anticoagulation in extracorporeal circuits is crucial to prevent blood clotting during procedures like hemodialysis, ECMO, and plasmapheresis. These circuits come in contact with foreign materials, which can trigger coagulation, leading to clot formation and circuit failure.
Step 1: Anticoagulation Methods:
1. Heparin: The most commonly used anticoagulant in extracorporeal circuits. It works by inhibiting thrombin and other clotting factors. Low-dose heparin is used to prevent clot formation, while high-dose heparin can be used in therapeutic situations.
2. Low-Molecular-Weight Heparin (LMWH): These are derivatives of heparin and have a more predictable anticoagulant effect. LMWH is less likely to cause bleeding complications compared to unfractionated heparin.
3. Direct Thrombin Inhibitors: Drugs like bivalirudin and argatroban directly inhibit thrombin and are used in patients who have heparin-induced thrombocytopenia (HIT) or other heparin-related issues.
4. Citrate: Citrate works by chelating calcium, which is necessary for the coagulation cascade. It is commonly used in renal replacement therapy and ECMO, particularly in patients with heparin allergies or HIT. Citrate requires careful monitoring to prevent metabolic disturbances like alkalosis or hypocalcemia.
Step 2: Monitoring and Adjustments:
Regular monitoring of activated partial thromboplastin time (aPTT) for heparin and ionized calcium levels for citrate is essential to prevent over-anticoagulation or under-anticoagulation.
Step 3: Challenges and Considerations:
1. Risk of Bleeding: Excessive anticoagulation can lead to bleeding complications, which is a significant concern in critically ill patients.
2. Management of Anticoagulation: Adjustments in dosing may be needed based on patient condition, the type of extracorporeal procedure, and the risk of clot formation versus bleeding.
Was this answer helpful?
0
0

Top Questions on Hemodynamic Monitoring & Support

Questions Asked in NEET SS (DrNB) exam

View More Questions